Skip to main content
. 2021 Jun 24;54:107361. doi: 10.1016/j.carpath.2021.107361

Fig. 2.

Fig 2:

(A) CD3 immunostaining, demonstrating a paucity of CD3+ lymphocytes in COVID-19. (B) CD68 immunostaining in COVID-19, highlighting a mild, diffuse distribution of CD68+ cells. (C) CD3 immunostaining in a case of myocarditis, demonstrating intense staining for CD3+ lymphocytes in a patchy distribution. (D) CD68 immunostaining in myocarditis, in a similar patchy distribution to that of lymphocytes, with example of region selection box for analysis.